Journal of Cell Science & Therapy
Open Access

Department of Clinical Immunology, Paris Saclay University, Paris, France

Biography

Dr. Olivier Lambotte is a distinguished Professor of Internal Medicine at Université Paris-Saclay and serves as a clinician at the Bicêtre Hospital in Le Kremlin-Bicêtre, France. His extensive research focuses on HIV persistence, immune checkpoint inhibitors, and the regulation of immune responses in infectious diseases. In the realm of HIV research, Dr. Lambotte has significantly contributed to understanding HIV reservoirs and the mechanisms underlying viral latency. He is notably involved in the ANRS VISCONTI study, which investigates post-treatment controllers—individuals who maintain viral suppression after discontinuing antiretroviral therapy. This work aims to uncover factors that could inform strategies toward achieving HIV remission.Dr. Lambotte's expertise extends to the immunological aspects of cancer therapy, particularly concerning immune-related adverse events (irAEs) associated with immune checkpoint inhibitors. His research in this area has been instrumental in characterizing the spectrum of irAEs and developing management strategies to mitigate these effects, thereby enhancing the safety and efficacy of cancer immunotherapies. 

Publications

• Perspective   
  Mechanism and Significant Characteristics of Immunotherapy
  Author(s): Oliver Lambotte*
  
  DOI: 10.35248/2157-7013.24.15.457

  HTML PDF